These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15328392)

  • 41. Highlights of the Medicare Prescription Drug Act.
    Conomikes GS
    J Okla State Med Assoc; 2005 Oct; 98(10):492-3. PubMed ID: 16296207
    [No Abstract]   [Full Text] [Related]  

  • 42. Improving the design of competitive bidding in Medicare Advantage.
    Cawley JH; Whitford AB
    J Health Polit Policy Law; 2007 Apr; 32(2):317-47. PubMed ID: 17463410
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What you need to know about the Medicare Prescription Drug Act.
    Brinckerhoff J; Coleman EA
    Fam Pract Manag; 2005 Mar; 12(3):49-52. PubMed ID: 15813305
    [No Abstract]   [Full Text] [Related]  

  • 44. Coverage and use of prescription drugs in nursing homes: implications for the medicare modernization act.
    Stuart B; Simoni-Wastila L; Baysac F; Shaffer T; Shea D
    Med Care; 2006 Mar; 44(3):243-9. PubMed ID: 16501395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medicare program; use of repayment plans. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Jun; 73(125):36443-8. PubMed ID: 18677827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medicare Program; termination of non-random prepayment complex medical review. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(188):55753-63. PubMed ID: 18985956
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medicare Part D subsidies. Final rules.
    Social Security Administration (SSA)
    Fed Regist; 2005 Dec; 70(250):77663-85. PubMed ID: 16392171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of the Medicare prescription drug benefit on home- and community-based services waiver programs.
    Milligan CJ
    Issue Brief (Commonw Fund); 2005 Apr; (815):1-8. PubMed ID: 15856612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 50. [KNMVD sees veterinary court decision about internet pharmacy Medpets in good hands].
    van Herten J
    Tijdschr Diergeneeskd; 2008 Oct; 133(19):815. PubMed ID: 18947053
    [No Abstract]   [Full Text] [Related]  

  • 51. Medicare program; Medicare prescription drug benefit; interpretation. Final rule; interpretation.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Mar; 70(53):13397-400. PubMed ID: 15786588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Medicare program; Medicare secondary payer amendments. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2006 Feb; 71(37):9466-71. PubMed ID: 16528852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality is access in the Medicare prescription drug benefit--for now.
    Teagarden JR
    Manag Care Interface; 2006 Jul; 19(7):25, 27. PubMed ID: 16898342
    [No Abstract]   [Full Text] [Related]  

  • 55. APhA federal pharmacy initiatives: supporting those in harm's way.
    Tackitt RD
    J Am Pharm Assoc (2003); 2007; 47(5):566. PubMed ID: 17848341
    [No Abstract]   [Full Text] [Related]  

  • 56. The Health Security Act: a case of good news and bad news.
    Wolfgang AP; Rupp MT
    Ann Pharmacother; 1994 Jun; 28(6):802-4. PubMed ID: 7919573
    [No Abstract]   [Full Text] [Related]  

  • 57. What Medicare Prescription Drug Act '03 means to hospitals.
    Falk RN
    Health Care Strateg Manage; 2004 May; 22(5):10-1. PubMed ID: 15192894
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter--A Challenge to the Pharmacy Profession to Raise Its Voice on Health Care Reform.
    Rubinstein E
    J Manag Care Spec Pharm; 2017 Dec; 23(12):1277. PubMed ID: 29172982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IACP's 2016 Compounders on Capitol Hill Asks.
    Int J Pharm Compd; 2016; 20(4):294-296. PubMed ID: 28333674
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacists in California HMOs gain expanded role.
    Wittenburg AS
    Am J Hosp Pharm; 1994 Dec; 51(23):2890, 2893. PubMed ID: 7879799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.